51
|
Harnoss JC, Elrub QMA, Jung JO, Koburger T, Assadian O, Dissemond J, Baguhl R, Papke R, Kramer A. Irritative potency of selected wound antiseptics in the hen's egg test on chorioallantoic membrane to predict their compatibility to wounds. Wound Repair Regen 2018; 27:183-189. [PMID: 30520197 DOI: 10.1111/wrr.12689] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2017] [Revised: 10/17/2018] [Accepted: 11/03/2018] [Indexed: 11/29/2022]
Abstract
Antiseptics are being used for prevention of infections in acute wounds and for treatment of infections in acute and chronic wounds. However, some antiseptics' high tissue toxicity might delay the healing process. The aim of this study was to investigate the tissue toxicity of preferentially used wound antiseptics and the influence of antiphlogistic additives via the hen's egg test on the chorioallantoic membrane (HET-CAM). The HET-CAM is a semi-in-vivo method testing the tissue tolerability of wound antiseptics by evaluating the blood vessel reaction of the chorioallantoic membrane in terms of hemorrhage, vessel lysis, and coagulation. For each test day, selected test substances were applied on the membranes of two to three eggs according to the test protocol. The overall irritation was then evaluated by referring to a calculated score. Normal distribution of the resulting scores was confirmed by D'Agostino-Pearson omnibus K2 test. Significant differences between the antiseptics were calculated by Tukey's multiple comparisons test. Severe CAM reactions were observed after short-term application of octenidine based wound gel (0.05%) and chlorhexidine digluconate (0.5% solution), moderate reactions for octenidine (0.05%) in aqueous solution combined with dexpanthenol (1.34%) and allantoin (0.2%) or for hydrogen peroxide (1.5% and 0.5%) in aqueous solution, slight reactions were observed for hydrogen peroxide (1.5%) in aqueous solution in combination with sodium thiocyanate (0.698%) and for the combination of NaOCl/HOCl (each 0.004%). Polyhexanide (0.04%) in Ringer solution and polyhexanide (0.05%) in Lipofundin, the hemoglobin spray (10%), dexpanthenol, and allantoin showed no irritation. The HET-CAM qualifies as a primary screening test for tissue tolerance of wound antiseptics. Regarding local tolerability, polyhexanide and hypochlorite are superior to other antiseptics.
Collapse
Affiliation(s)
- Julian Camill Harnoss
- Department of General, Visceral and Transplantation Surgery and Study Center of the German Surgical Society, University Hospital Heidelberg, Heidelberg, Germany
| | - Qasim Mahmoud Abu Elrub
- Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Jin-On Jung
- Department of General, Visceral and Transplantation Surgery and Study Center of the German Surgical Society, University Hospital Heidelberg, Heidelberg, Germany
| | | | - Ojan Assadian
- Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
| | - Joachim Dissemond
- Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany
| | - Romy Baguhl
- Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Roald Papke
- Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Axel Kramer
- Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany
| | | |
Collapse
|
52
|
Skin Integrity and Infection Prevention Las Vegas: continuous delivery of oxygen enhances closure of diabetic foot ulcers. J Wound Care 2018; 27:856-857. [DOI: 10.12968/jowc.2018.27.12.856] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
53
|
Kaufman H, Gurevich M, Tamir E, Keren E, Alexander L, Hayes P. Topical oxygen therapy stimulates healing in difficult, chronic wounds: a tertiary centre experience. J Wound Care 2018; 27:426-433. [PMID: 30016136 DOI: 10.12968/jowc.2018.27.7.426] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Oxygen plays a central role in wound healing. Recent technological advances have miniaturised oxygen delivery systems, with novel topical oxygen therapy allowing patients to receive oxygen therapy 24 hours a day while remaining completely mobile. Here we aim to examine the efficacy and safety of continuous topical oxygen diffusion in a 'real-world' setting. METHODS Topical oxygen therapy (TOT) was evaluated in patients with chronic, non-healing wounds in a tertiary referral specialist clinic. RESULTS The mean wound duration before TOT was 15 months. Regardless of treatment duration, in this previously non-healing group complete wound closure was observed in 32% of the total patients treated with the TOT device. However, optimal wound healing occurred when the device was used for >25 days, with an 83% wound area reduction and 47% wound closure rate seen in venous leg ulcers (VLUs) and a 74% reduction and a 57% wound closure rate in arterial foot ulcers. CONCLUSION Use of TOT in chronic wounds stimulates a healing state. In our study, almost half of the previously non-healing wounds closed.
Collapse
Affiliation(s)
- Hanna Kaufman
- Head of Department; 1Northern District Trauma & Wound Clinics Division, "Maccabi" Health Care Services
| | | | - Eran Tamir
- Orthopaedic Surgeon; Department of Orthopaedic Surgery, Assaf HaRofeh Medical Center, Zerrifin, Affiliated to the Sackler School of Medicine, Tel Aviv University, Israel
| | - Elad Keren
- Orthopaedic Surgeon; Maccabi healthcare services Beer Sheva. Israel, and Orthopaedic department Soroka Medical Center Beer Sheva, Israel
| | - Lipkin Alexander
- Senior Orthopaedic Surgeon; Department of Chronic Wounds, Maccabi health care services, Rishon Lezion, Israel, and Wolfson Medical Center, Foot and Ankle unit, Holon, Israel
| | - Paul Hayes
- Vascular Surgeon; Department of Vascular Surgery, Addenbrooke's Hospital, Cambridge, UK
| |
Collapse
|
54
|
Piaggesi A, Låuchli S, Bassetto F, Biedermann T, Marques A, Najafi B, Palla I, Scarpa C, Seimetz D, Triulzi I, Turchetti G, Vaggelas A. Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies. J Wound Care 2018; 27:S1-S137. [DOI: 10.12968/jowc.2018.27.sup6a.s1] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Alberto Piaggesi
- Prof, Director, EWMA Scientific Recorder (Editor), Diabetic Foot Section of the Pisa University Hospital, Department of Endocrinology and Metabolism, University of Pisa, Lungarno Pacinotti 43, 56126 Pisa, Italy
| | - Severin Låuchli
- Chief of Dermatosurgery and Woundcare, EWMA Immediate Past President (Co-editor), Department of Dermatology, University Hospital, Zurich, Råmistrasse 100, 8091 Zärich, Schwitzerland
| | - Franco Bassetto
- Prof, Head of Department, Clinic of Plastic and Reconstructive Surgery, University of Padova, Via Giustiniani, 35100 Padova
| | - Thomas Biedermann
- Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, August Forel-Strasse 7, 8008 Zürich, Switzerland
| | - Alexandra Marques
- University of Minho, 3B's Research Group in Biomaterials, Biodegradables and Biomimetics, Avepark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco GMR, Portugal
| | - Bijan Najafi
- Professor of Surgery, Director of Clinical Research, Division of Vascular Surgery and Endovascular Therapy, Director of Interdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, MS: BCM390, Houston, TX 77030-3411, US
| | - Ilaria Palla
- Institute of Management, Sant'Anna School of Advanced Studies, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy
| | - Carlotta Scarpa
- Clinic of Plastic and Reconstructive Surgery, University of Padova, Via Giustiniani, 35100 Padova
| | - Diane Seimetz
- Founding Partner, Biopharma Excellence, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, 80992 Munich, Germany
| | - Isotta Triulzi
- Institute of Management, Sant'Anna School of Advanced Studies, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy
| | - Giuseppe Turchetti
- Fulbright Scholar, Institute of Management, Sant'Anna School of Advanced Studies, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy
| | - Annegret Vaggelas
- Consultant, Biopharma Excellence, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, 80992 Munich, Germany
| |
Collapse
|
55
|
Ousey K, Chadwick P, Jawień A, Tariq G, Nair HKR, Lázaro-Martínez JL, Sandy-Hodgetts K, Alves P, Wu S, Moore Z, Pokorná A, Polak A, Armstrong D, Sanada H, Hong JP, Atkin L, Santamaria N, Tehan P, Lobmann R, Fronzo C, Webb R. Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives. J Wound Care 2018; 27:S1-S52. [DOI: 10.12968/jowc.2018.27.sup5.s1] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
| | | | - Arkadiusz Jawień
- Collegium Medicum, University of Nicolaus Copernicus, Bydgoszcz, Poland
| | - Gulnaz Tariq
- Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
| | | | | | | | - Paulo Alves
- Institute of Health Sciences, Catholic University of Portugal, Portugal
| | - Stephanie Wu
- Dr William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science, United States
| | - Zena Moore
- Royal College of Surgeons in Ireland, Dublin, Republic of Ireland
| | | | - Anna Polak
- Jerzy Kukuczka Academy of Physical Education in Katowice, Poland
| | - David Armstrong
- Keck School of Medicine of University of Southern California, United States
| | | | - Joon Pio Hong
- Asan Medical Centre, University of Ulsan, South Korea
| | | | - Nick Santamaria
- University of Melbourne and Royal Melbourne Hospital, New South Wales, Australia
| | | | | | | | | |
Collapse
|
56
|
Howell RS, Criscitelli T, Woods JS, Gillette BM, Gorenstein S. Hyperbaric Oxygen Therapy: Indications, Contraindications, and Use at a Tertiary Care Center. AORN J 2018; 107:442-453. [DOI: 10.1002/aorn.12097] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
57
|
Hayes P, Alzuhir N, Curran G, Loftus I. Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: a pilot study. J Wound Care 2017; 26:652-660. [DOI: 10.12968/jowc.2017.26.11.652] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- P.D. Hayes
- Consultant Vascular Surgeon, Department of Vascular Surgery, Cambridge University Hospitals NHS Trust, Addenbrooke's Hospital, UK
| | - N. Alzuhir
- Clinical Research Fellow, Department of Vascular Surgery, Cambridge University Hospitals NHS Trust, Addenbrooke's Hospital, UK
| | - G. Curran
- Clinical Research Fellow, Department of Vascular Surgery, Cambridge University Hospitals NHS Trust, Addenbrooke's Hospital, UK
| | - I.M. Loftus
- Consultant Vascular Surgeon, St George's Vascular Unit, St George's Healthcare NHS Trust, Tooting, London, UK
| |
Collapse
|
58
|
Hunt S, Elg F. The clinical effectiveness of haemoglobin spray as adjunctive therapy in the treatment of chronic wounds. J Wound Care 2017; 26:558-568. [DOI: 10.12968/jowc.2017.26.9.558] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- S. Hunt
- Lead Nurse Advanced Nurse Practitioner, Wellway Medical Group, Northumberland, Berwick Upon Tweed, UK
| | - F. Elg
- Consultant Statistician, Pracipio Ltd, London, UK
| |
Collapse
|
59
|
Hunt S. Topical oxygenation therapy in wound care: are patients getting enough? BRITISH JOURNAL OF NURSING (MARK ALLEN PUBLISHING) 2017; 26:S28-S36. [PMID: 28792822 DOI: 10.12968/bjon.2017.26.15.s28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Wound management is a major burden on today's healthcare provider, both clinically with regard to available resources and financially. Most importantly, it has a significant impact on the patient's quality of life and experience. Within the field of wound care these pressures, alongside an ageing population, multiple comorbidities, disease processes and negative lifestyle choices, increase incidences of reduced skin integrity and challenging wounds. In an attempt to meet these challenges alternative, innovative therapies are being explored to support the wound healing process. Wound care experts are now exploring the scientific, biological aspects of wound healing at a cellular level. They are taking wound care back to basics with the identification of elements that, if introduced as an 'adjunct' or as a stand-alone device alongside gold-standard regimens, can positively impact the static or problematic wounds that pose the most challenges to clinicians on a daily basis. This article explores the phenomenon of oxygen, its place in tissue formation and the effect of depletion on the wound healing process and highlights ways in which patients may receive benefit from non-invasive intervention to improve wound care outcomes.
Collapse
Affiliation(s)
- Sharon Hunt
- Lead Advanced Nurse Practitioner/ANP Manager, Independent Specialist in Wound Care, Valens Partnership Group
| |
Collapse
|